Michroma, a biotech platform dedicated to producing natural ingredients, has secured $290,284 in new investment capital from investors. This funding round underscores the market's interest in sustainable and innovative solutions for the ingredient sector. The company's unique approach leverages synthetic biology to develop proprietary strains of filamentous fungi, enabling the production of high-performance ingredients in bioreactors in a sustainable, scalable, and cost-effective manner.
The company's initial focus is on developing extremely pH and thermal stable food colorants, which are currently being prototyped with leading food and beverage alongside cosmetic companies globally. Michroma's technology offers an alternative to traditional ingredient sourcing, addressing demand for clean label products and environmentally friendly production methods. The capital raised will be instrumental in accelerating the development of these pioneering products and expanding the company's technological capabilities.
Michroma plans to strategically deploy these funds to further its growth initiatives, including enhancing research and development efforts and scaling its proprietary platform. This investment will support the advancement of its ingredient pipeline, which also includes the production of mycoprotein and a variety of other future ingredients. The company, which was accelerated by Indiebio (Batch 9) and is part of Mista, operates from bases in Rosario, Argentina, and San Francisco, USA.
This latest funding infusion is expected to bolster Michroma's mission to transform the natural ingredient landscape. By expanding its production capabilities and diversifying its product offerings, Michroma aims to establish itself as a key player in providing high-performance, sustainably produced ingredients to a global market. The company looks forward to scaling its operations and bringing more innovative ingredients to commercialization.
.png&w=3840&q=75)
